Weight Maintenance in Adolescents With Obesity; Long-Term Treatment With Semaglutide s.c.2.4 mg Once-weekly
Latest Information Update: 15 Apr 2025
At a glance
- Drugs Semaglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 27 Sep 2024 Status changed from not yet recruiting to recruiting.
- 29 Aug 2024 New trial record